Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Fried gator to chicken alfredo: Flavors driving KC Cajun to entrepreneur’s next phase
Kansas City businesses should utilize every resource at their disposal to build stronger brands, said Israel England, owner and operator of KC Cajun. “I’m branching out,” England said with confidence as he detailed his coming venture — adapting his KC Cajun catering service into a food truck. “There is so much more room to improve,…
LaunchKC finalists revealed: Kansas City newsmakers and startup stars in the making
A dozen Kansas City tech entrepreneurs are set to compete next month against a mix of firms from across the country — and one startup from Israel — in arguably the city’s most elite and hotly anticipated pitch event of the year. LaunchKC announced its 20 finalists Tuesday — each vying for their piece of…
‘Buddha was a Baller’ seeks to awaken success without overthinking, Mindsport founder says
Buddha had the mind of an athlete, said Ryan Stock. The spiritual sage on whose teachings Buddhism was founded inspired Stock, creator of the MindSport app and a former basketball coach, to put his own thoughts to paper. His book, “Buddha was a Baller,” is set for release Oct. 28, the Kansas City entrepreneur said.…
Pipeline opens applications for 2019 fellowship class, reveals three-city 1MC pitch event
An application for Pipeline’s 2019 fellowship class isn’t just about next year, said Joni Cobb — it’s an opportunity for a lifetime of support from the organization’s network of developing and top-tier entrepreneurs. “Pipeline is available for life for each entrepreneur who successfully completes the fellowship year,” said Cobb, president and CEO of Pipeline, in…